Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U7 small nuclear 26 pseudogene (RNU7-26P)** is a pseudogene corresponding to the U7 small nuclear RNA gene family. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations that prevent expression or the formation of a functional product. U7 small nuclear RNA is an essential component of the U7 snRNP complex, which is required for the 3' end processing of replication-dependent histone pre-mRNAs, but RNU7-26P itself is a non-functional, processed pseudogene with no known biological activity or role in disease[1][6]. It is not considered a receptor, enzyme, or therapeutic target. Functional U7 snRNA is necessary for histone pre-mRNA 3' end formation, operating as part of the U7 snRNP complex involved in cell cycle-regulated mRNA maturation, but the pseudogene form, RNU7-26P, does not participate in these processes[3][5][6]. **Notes:** - The **canonical gene** encoding the functional RNA in humans is RNU7-1, not RNU7-26P; many pseudogene copies of U7 snRNA exist in the genome but do not perform the function of the authentic snRNA[6]. - There is **nothing to support that RNU7-26P has any utility as a therapeutic or diagnostic target**; its annotation as a "target" is incorrect and its biological function is essentially null. - The entry is **not a protein, receptor, or enzyme**, and does not bind known drugs or serve as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 26 pseudogene (RNU7-26P).